{
    "title": "Copper Aspirinate - Properties & Preparation",
    "inventor_name": "John R. J. Sorenson",
    "publication_year": 2000,
    "device_name": "Copper Aspirinate",
    "goal": "Provide therapeutic treatment for inflammatory diseases, ulcers, arthritis, and related conditions using a copper-based metallo-organic complex.",
    "problem_addressed": "Inflammatory diseases (e.g., rheumatoid arthritis), gastric ulcers, infections, seizures, cancers, radiation-induced tissue damage, cardiovascular disease.",
    "concept_summary": "Copper aspirinate is a metallo-organic complex of copper and aspirin (acetylsalicylic acid). The copper ion chelates the aspirin molecule, enhancing anti-inflammatory activity while reducing gastrointestinal side effects. Historical and modern studies suggest the complex accelerates wound healing, exhibits anticonvulsant, anticancer, and radiation-protective properties, and may support cardiovascular health.",
    "detailed_description": "The compound is prepared by reacting copper salts (e.g., copper acetate) with aspirin under controlled conditions to form a stable copper-aspirinate complex. The resulting solid can be administered orally or topically. Pre-clinical animal studies have shown faster ulcer healing and improved anti-inflammatory efficacy compared with aspirin alone. Clinical anecdotes from early 20th-century medicine and limited modern trials indicate potential benefits across a range of disease states, but large-scale randomized studies are lacking.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Metallo-organic chelation",
        "Enhanced anti-inflammatory activity",
        "Antioxidant (free-radical scavenging) effect",
        "Improved bioavailability of copper"
    ],
    "scientific_domains": [
        "Pharmacology",
        "Medicine",
        "Biochemistry"
    ],
    "mechanisms_of_action": [
        "Inhibition of cyclooxygenase via aspirin moiety",
        "Copper-mediated antioxidant activity",
        "Modulation of immune response",
        "Stabilization of tissue repair processes"
    ],
    "materials": [
        "Copper (Cu)",
        "Aspirin (acetylsalicylic acid)",
        "Copper acetate",
        "Copper oxide"
    ],
    "energy_sources": [],
    "inputs": [
        "Copper salt",
        "Aspirin",
        "Solvent (e.g., water or ethanol)",
        "Heat or stirring"
    ],
    "outputs": [
        "Copper aspirinate solid"
    ],
    "claimed_performance": "More effective than aspirin alone for rheumatoid arthritis; heals gastric ulcers up to five days faster; reduces ulceration associated with NSAID therapy; exhibits anticonvulsant, anticancer, and radiation-protective effects in animal models.",
    "experimental_evidence": "Animal studies demonstrating accelerated ulcer healing and anti-inflammatory efficacy; historical clinical use for arthritis, tuberculosis, and other ailments; early 20th-century reports of copper compounds inducing vomiting; modern pre-clinical data on radiation protection and tumor growth inhibition.",
    "replication_status": "Limited to animal research and historical clinical anecdotes; no large-scale modern clinical trials documented in the article.",
    "keywords": [
        "copper aspirinate",
        "copper complexes",
        "NSAID enhancement",
        "wound healing",
        "anti-inflammatory",
        "antioxidant",
        "radiation protection"
    ],
    "related_technologies": [
        "Copper sulfate",
        "Copper chloride",
        "Copper tryptophanate",
        "Non-steroidal anti-inflammatory drugs (NSAIDs)"
    ],
    "controversy_level": "low",
    "confidence_score": 0.8,
    "practicability_score": 0.7,
    "fringe_score": 0.2,
    "evidence_strength": 0.6,
    "risk_score": 0.3,
    "trl_estimate": 5,
    "source_urls": [
        "http://en.wikipedia.org/w/index.php?title=Copper_aspirinate&oldid=465679308"
    ],
    "organizations": [
        "University of Arkansas for Medical Sciences",
        "Copper Development Association"
    ],
    "applications": [
        "Rheumatoid arthritis treatment",
        "Gastric ulcer healing",
        "Anticonvulsant therapy",
        "Adjunct cancer therapy",
        "Radiation injury mitigation",
        "Cardiovascular disease prevention"
    ],
    "limitations": [
        "Lack of large-scale modern clinical trials",
        "Potential copper toxicity at high doses",
        "Variability in formulation purity"
    ],
    "open_questions": [
        "Optimal dosing regimen for different indications",
        "Long-term safety and copper accumulation in humans",
        "Precise molecular mechanisms of anticancer activity",
        "Effectiveness compared with newer biologic therapies"
    ],
    "red_flags": [
        "Reliance on historical anecdotal evidence",
        "Absence of peer-reviewed randomized controlled trials",
        "Possible overstating of efficacy without quantitative data"
    ],
    "evidence_quotes": [
        "Copper aspirinate has been shown not only to be more effective in the treatment of rheumatoid arthritis than aspirin alone, but it has been shown to prevent or even cure the ulceration of the stomach often associated with aspirin therapy.",
        "Copper complexes heal gastric ulcers five days sooner than other reagents.",
        "Copper complexes of all anti-epileptic drugs are more effective and less toxic than their parent drugs.",
        "Treatment of solid tumors with non-toxic doses of various organic complexes of copper markedly decreased tumor growth and metastasis and thus increased survival rate.",
        "Copper metallo-organic complexes have been shown to have radiation protection and radiation recovery activities."
    ]
}